Concepedia

Publication | Closed Access

Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma

DOI

98

Citations

32

References

2013

Year

Anna Raciborska, Katarzyna Bilska, Katarzyna Drabko, Radosław Chaber, Monika Pogorzała, Elżbieta Wyrobek, Katarzyna Połczyńska, Elżbieta Rogowska, Carlos Rodríguez‐Galindo, Wojciech Woźniak
Pediatric Blood & Cancer

Abstract

The shorter, 5-day VIT regimen is an active and well-tolerated regimen in refractory ES. This combination deserves further investigation in the upfront management of patients with metastatic disease.

References

YearCitations

Page 1